The global demand for Helicobacter Pylori Non-Invasive Testing Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Helicobacter pylori non-invasive testing is used when an individual's stomach is infected by H. pylori bacterium. Helicobacter pylori is a very motile, curved rod-shaped gram-negative bacterium with multiple flagella that lives in the gastric mucous-coated lining and the gastric pits of the epithelial tissue of the stomach. Once it enters the stomach, it colonizes in the stomach linings causing stomach infections. These infections can later lead to gastroenteritis or peptic ulcers. The various non-invasive tests that can diagnose this infection include serology, detection of labelled metabolic products of urea hydrolysis in the breath (13CO2, 14CO2), the urine or the blood, and detection of H. pylori antigen in a stool specimen etc.
Market Dynamics
The key factor driving the demand for the helicobacter pylori non-invasive testing market is the rise in the frequency of helicobacter pylori bacterial infection. An increase in the use of non-invasive testing for the diagnosis of H. pylori and the scarcity of endoscopic facilities are boosting the demand for this market. Rising demand for point-of-care testing equipment and easy availability of diagnostics tests are further pushing the demand for this market. The rise in government awareness of infection for accurate diagnosis, increasing technological advancements and the number of innovations, together with new product launches and FDA approvals, are fostering the demand for this market. However, stringent regulatory standards can hamper the growth of this market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of helicobacter pylori non-invasive testing. The growth and trends of helicobacter pylori non-invasive testing industry provide a holistic approach to this study.
Market Segmentation
This section of the helicobacter pylori non-invasive testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Serology Test
- Stool Antigen Test
- Urea Breath Test
By Application
- Hospitals
- Physical Examination Centers
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Helicobacter Pylori Non-Invasive Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Helicobacter Pylori Non-Invasive Testing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the helicobacter pylori non-invasive testing market include Sekisui Diagnostics, Roche, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Cardinal Health, Danaher, Agilent Technologies, Coris BioConcept. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
